RecruitingNot Applicable

Hormonal Management of Heavy Menstrual Bleeding in Adolescents

Switzerland163 participantsStarted 2024-12-17

Plain-language summary

The goal of this study is to evaluate whether hormonal medications (such as contraceptive pill, patch, injectable progestins and hormonal intra-uterine device) have similar efficacy at managing heavy menstrual bleeding in adolescents with a bleeding disorder compared to those without. We also aim to assess the quality of life and hemoglobin and iron levels in this population.

Who can participate

Age range

25 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adolescents and young adults aged \< 26yo * Presenting to the gynecology consultation at HUG * Diagnosed with heavy menstrual bleeding (PBAC \> 100) * Willing to initiate a hormonal medication to manage heavy menstrual bleeding Exclusion Criteria: * Pregnancy or planning to become pregnant during the study period * Already using hormonal medication for menstrual management and/or contraception * Known anatomical uterine pathology * Using anticoagulant or antiaggregant agents

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Percentage of reduction in menstrual blood loss

Timeframe: 6 months after hormonal medication initiation

Trial details

NCT IDNCT06740929

SponsorUniversity Hospital, Geneva

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-07

Contact for this trial

Dehlia Moussaoui, MD

+41 22 372 33 87 dehlia.moussaoui@hug.ch

View on ClinicalTrials.gov More Heavy Menstrual Bleeding trials